Accretion Pharmaceuticals Limited

Company Name	Accretion Pharmaceuticals Limited
Open Date	14-05-2025
Close Date	16-05-2025
Exchange	NSE SME
Lot Size	1,000 Shares
Issue Price	₹96 to ₹101 per share
Issue Size	29,46,000 shares
Application Amount	₹1,21,200
Recommendation	Avoid

Accretion Pharmaceuticals Limited was originally incorporated on Dec 18, 2012. The registered office is located at Ahemdabad, Gujarat. The company is engaged in the business of manufacturing and marketing of tablets, capsules, oral liquid, external preparations and oral powder. The company generates majority of the revenue from the manufacturing of tablets. The company has 105 full-time employees as on May 06, 2025.

(Read more on the review)

Summary of Financials (All financials in Lakh)

KPIs	Mar-22	Mar-23	Mar-24	Dec-24
Revenue	2,229.20	2,938.43	3,366.52	3,566.73
EBITDA	163.88	199.13	748.93	874.25
Net Profit	7.90	10.39	387.52	523.55
RoCE	13.78%	15.82%	53.64%	23.09%*
ROE	2.57%	2.70%	72.47%	15.46%*
P/E	505.00	388.46	10.42	16.11*

Tentative Timeline

Opening Date	14-05-2025
Closing Date	16-05-2025
Basis of Allotment	19-05-2025
Initiation of Refunds	20-05-2025
Credit of Shares to Demat	20-05-2025
Listing Date	21-05-2025

Objects of the Issue

Capital expenditure towards purchase of new equipment/ machineries, etc.

Capital expenditure towards upgradation of existing manufacturing facility

Repayment/prepayment of certain borrowings availed by the Company

Funding working capital requirements

General Corporate Purposes

Contact Information

Registered Office	29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand,
Phone	compliance@accretionpharma.com
Email	investors@vgipl.in
Website	https://accretionpharma.com/

Offer Documents

Accretion Pharmaceuticals IPO DRHP

Accretion Pharmaceuticals IPO RHP

Registrar Details

Name	Kfin Technologies Limited
Phone	04067162222, 04079611000
Email	apl.ipo@kfintech.com
Website	https://kosmic.kfintech.com/ipostatus/

IPO Reservation

QIB Shares Offered	Not more than 50.00% of the Net Issue
NII (HNI) Shares Offered	Not more than 15.00% of the Net Issue
Retail Shares Offered	Not less than 35.00% of the Net Issue

Shareholding Pattern

Share Holding Pre Issue (Promoters)	100.00%
Share Holding Post Issue (Promoters)	73.50%